Coffee compound may slow prostate cancer return in small trial
NCT ID NCT05478239
First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 33 times
Summary
This study tests a special coffee made from the Artemisia annua plant (ArtemiCoffee) in 20 men whose prostate cancer has returned after initial treatment, shown by rising PSA levels. The goal is to see if drinking this coffee can lower PSA by at least 50% within 24 weeks. It is a Phase 2 trial, meaning it checks for early signs of effectiveness and safety.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Kentucky
Lexington, Kentucky, 40536, United States
Conditions
Explore the condition pages connected to this study.